Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence

AIMS: To evaluate the efficacy and safety of the PROMETA™ Protocol for treating methamphetamine dependence. DESIGN: A double-blind, placebo-controlled 108-day study with random assignment to one of two study conditions: active medication with flumazenil (2 mg infusions on days 1, 2, 3, 22, 23), gaba...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ling, Walter, Shoptaw, Steven, Hillhouse, Maureen, Bholat, Michelle A., Charuvastra, Charles, Heinzerling, Keith, Chim, David, Annon, Jeffrey, Dowling, Patrick T., Doraimani, Geetha
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122522/
https://ncbi.nlm.nih.gov/pubmed/22082089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1360-0443.2011.03619.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы